787732000: Risankizumab (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Immunologic agent (substance)\Substance with interleukin 23 receptor antagonist mechanism of action (substance)\Risankizumab
\Drug or medicament (substance)\Immunosuppressant (substance)\Risankizumab
\Drug or medicament (substance)\Monoclonal antibody\Risankizumab

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Risankizumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Risankizumab

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Risankizumab
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Risankizumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3776694016 Risankizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3776695015 Risankizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1133751000172119 risankizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

1126311000172112 risankizumab nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Risankizumab	Is a	Substance with interleukin 23 receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some
Risankizumab	Has disposition (attribute)	Interleukin 23 receptor antagonist (disposition)	true	Inferred relationship	Some
Risankizumab	Is a	Murine-human monoclonal immunoglobulin G antibody	false	Inferred relationship	Some
Risankizumab	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some
Risankizumab	Is a	Monoclonal antibody	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing risankizumab (medicinal product)	Has active ingredient	True	Risankizumab	Inferred relationship	Some	1
Risankizumab-containing product in parenteral dose form	Has active ingredient	True	Risankizumab	Inferred relationship	Some	1
Risankizumab only product in parenteral dose form	Has active ingredient	True	Risankizumab	Inferred relationship	Some	1
Risankizumab only product	Has active ingredient	True	Risankizumab	Inferred relationship	Some	1
Risankizumab 150 mg/mL solution for injection	Has precise active ingredient	True	Risankizumab	Inferred relationship	Some	1
Risankizumab 150 mg/mL solution for injection	Has basis of strength substance (attribute)	True	Risankizumab	Inferred relationship	Some	1
Product containing precisely risankizumab 90.361 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Risankizumab	Inferred relationship	Some	1
Product containing precisely risankizumab 90.361 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Risankizumab	Inferred relationship	Some	1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug